DE602006020489D1 - Cb1-rezeptormodulatoren - Google Patents

Cb1-rezeptormodulatoren

Info

Publication number
DE602006020489D1
DE602006020489D1 DE602006020489T DE602006020489T DE602006020489D1 DE 602006020489 D1 DE602006020489 D1 DE 602006020489D1 DE 602006020489 T DE602006020489 T DE 602006020489T DE 602006020489 T DE602006020489 T DE 602006020489T DE 602006020489 D1 DE602006020489 D1 DE 602006020489D1
Authority
DE
Germany
Prior art keywords
receptor modulators
modulators
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006020489T
Other languages
English (en)
Inventor
Josephus H M Lange
Der Neut Martina A W Van
Vliet Bernard J Van
Bakker Wouter I Iwema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Abbott Healthcare Products BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products BV filed Critical Abbott Healthcare Products BV
Priority claimed from PCT/EP2006/069878 external-priority patent/WO2007071662A1/en
Publication of DE602006020489D1 publication Critical patent/DE602006020489D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602006020489T 2005-12-20 2006-12-19 Cb1-rezeptormodulatoren Active DE602006020489D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75166705P 2005-12-20 2005-12-20
EP05112482 2005-12-20
PCT/EP2006/069878 WO2007071662A1 (en) 2005-12-20 2006-12-19 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators

Publications (1)

Publication Number Publication Date
DE602006020489D1 true DE602006020489D1 (de) 2011-04-14

Family

ID=35749602

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006020489T Active DE602006020489D1 (de) 2005-12-20 2006-12-19 Cb1-rezeptormodulatoren

Country Status (8)

Country Link
CN (1) CN101341127A (de)
AR (1) AR058370A1 (de)
AT (1) ATE500228T1 (de)
BR (1) BRPI0620035A2 (de)
DE (1) DE602006020489D1 (de)
SA (1) SA06270469B1 (de)
TW (1) TW200730500A (de)
ZA (1) ZA200804926B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079935A1 (es) * 2010-01-29 2012-02-29 Abbott Healthcare Products Bv Sintesis de derivados de pirazolin carboxamidina sustituida
JP2014510026A (ja) * 2011-01-07 2014-04-24 ターガセプト,インコーポレイテッド ニコチン受容体の非競合的アンタゴニスト
CN107417578B (zh) * 2017-08-23 2020-02-07 沈阳海诺威医药科技有限公司 N-(3,5-二甲基金刚烷-1-基)-n’-取代苯基脲类化合物及其制备方法和用途

Also Published As

Publication number Publication date
CN101341127A (zh) 2009-01-07
ZA200804926B (en) 2009-04-29
TW200730500A (en) 2007-08-16
ATE500228T1 (de) 2011-03-15
SA06270469B1 (ar) 2010-07-25
AR058370A1 (es) 2008-01-30
BRPI0620035A2 (pt) 2011-10-25

Similar Documents

Publication Publication Date Title
DK2653465T3 (da) Opioid-receptormodulatorer
ATE540027T1 (de) Tetrahydroindazol-cannabinoidmodulatoren
DK1889198T3 (da) Farma-informatiksystem
ATE509022T1 (de) Nikotin-acetylcholin-rezeptorsubtyp-selektive diazabicycloalkanamide
IL198990A0 (en) Cb1 receptor modulators
DK2447252T3 (da) Theramuteinmodulatorer
BRPI0813230A2 (pt) Moduladores de calicreína 7
IL191766A0 (en) Gaba-b receptor modulators
DK2000920T3 (da) Netværkssystem
DE602006018435D1 (de) Surround-System
BRPI0822061A2 (pt) Moduladores do receptor canabinoide
ATE492543T1 (de) 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidi - 2-one als cb1-rezeptor-modulatoren
DE602006011753D1 (de) Sigma-delta-modulatoren
BRPI0816154A2 (pt) Moduladores canabinóides de 5-vinilfenil-1-fenil-pirazol substituídos
ZA200805405B (en) Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
DE112007001747A5 (de) Möbelscharnier
DE602006005138D1 (de) Nichtsteroide glucocorticoid-rezeptormodulatoren
GB0622569D0 (en) Cannabinoid receptor modulators
DE602006020489D1 (de) Cb1-rezeptormodulatoren
DE602007008589D1 (de) Pyridooxazepin-progesteronrezeptor-modulatoren
ZA200806237B (en) Cannibinoid receptor modulators
NL2000351A1 (nl) Estrogeen-modulatoren.
ZA200904663B (en) CB1 receptor modulators
DE102006045883A8 (de) Scharnier
DE602005003564D1 (de) Progesteronrezeptormodulatoren